These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 16982510)

  • 1. Circulating adiponectin levels in Kawasaki disease.
    Takeshita S; Takabayashi H; Yoshida N
    Acta Paediatr; 2006 Oct; 95(10):1312-4. PubMed ID: 16982510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Value of serum soluble interleukin-2R, interleukin-6 and C-reactive protein in the early diagnosis of Kawasaki disease].
    Peng Q; Wu Q; Chen CH; Hong H; Zhang LY
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Jun; 8(3):208-10. PubMed ID: 16787593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interleukin 6 activities and tumor necrosis factor-alpha levels in serum of patients with Kawasaki disease].
    Matsubara T
    Arerugi; 1991 Feb; 40(2):147-54. PubMed ID: 2069514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of myeloid-related protein-8 and -14 in patients with acute Kawasaki disease.
    Hirono K; Foell D; Xing Y; Miyagawa-Tomita S; Ye F; Ahlmann M; Vogl T; Futatani T; Rui C; Yu X; Watanabe K; Wanatabe S; Tsubata S; Uese K; Hashimoto I; Ichida F; Nakazawa M; Roth J; Miyawaki T
    J Am Coll Cardiol; 2006 Sep; 48(6):1257-64. PubMed ID: 16979015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated circulating tumor necrosis factor-alpha in patients with Kawasaki disease.
    Maury CP; Salo E; Pelkonen P
    J Lab Clin Med; 1989 May; 113(5):651-4. PubMed ID: 2715685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated levels of high-sensitivity C-reactive protein and serum amyloid-A late after Kawasaki disease: association between inflammation and late coronary sequelae in Kawasaki disease.
    Mitani Y; Sawada H; Hayakawa H; Aoki K; Ohashi H; Matsumura M; Kuroe K; Shimpo H; Nakano M; Komada Y
    Circulation; 2005 Jan; 111(1):38-43. PubMed ID: 15611368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between adipokines and coronary artery aneurysm in children with Kawasaki disease.
    Liu R; He B; Gao F; Liu Q; Yi Q
    Transl Res; 2012 Aug; 160(2):131-6. PubMed ID: 22683371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The acute phase nature of interleukin 6: studies in Kawasaki disease and other febrile illnesses.
    Ueno Y; Takano N; Kanegane H; Yokoi T; Yachie A; Miyawaki T; Taniguchi N
    Clin Exp Immunol; 1989 Jun; 76(3):337-42. PubMed ID: 2473858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma leptin and adiponectin in COPD exacerbations: associations with inflammatory biomarkers.
    Krommidas G; Kostikas K; Papatheodorou G; Koutsokera A; Gourgoulianis KI; Roussos C; Koulouris NG; Loukides S
    Respir Med; 2010 Jan; 104(1):40-6. PubMed ID: 19782551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased serum levels of macrophage migration inhibitory factor in patients with Kawasaki disease.
    Lee TJ; Chun JK; Yeon SI; Shin JS; Kim DS
    Scand J Rheumatol; 2007; 36(3):222-5. PubMed ID: 17657678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Circulating interleukin-4 levels in acute phase Kawasaki disease].
    Hirao J; Hibi S; Andoh T; Ichimura T
    Arerugi; 1996 Oct; 45(10):1137-9. PubMed ID: 8958662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serum gamma interferon levels in relation to tumor necrosis factor and interleukin 2 receptor in patients with Kawasaki disease involving coronary-artery lesions].
    Matsubara T
    Arerugi; 1990 Feb; 39(2 Pt 1):118-23. PubMed ID: 2112909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [TNF-alpha, C-reactive protein and serum adiponectin modified in infertile patients with insulin resistance].
    Vital Reyes VS; López Alarcón M; Zavala Ortega I; Hinojosa Cruz JC; Téllez Velasco S; Gris Calvo J
    Ginecol Obstet Mex; 2008 Nov; 76(11):659-66. PubMed ID: 19065817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum soluble E-selectin levels in Kawasaki disease.
    Kim DS; Lee KY
    Scand J Rheumatol; 1994; 23(5):283-6. PubMed ID: 7526448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute Kawasaki disease is associated with reverse regulation of soluble receptor for advance glycation end products and its proinflammatory ligand S100A12.
    Wittkowski H; Hirono K; Ichida F; Vogl T; Ye F; Yanlin X; Saito K; Uese K; Miyawaki T; Viemann D; Roth J; Foell D
    Arthritis Rheum; 2007 Dec; 56(12):4174-81. PubMed ID: 18050248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of fenofibrate on adiponectin and inflammatory biomarkers in metabolic syndrome patients.
    Rosenson RS
    Obesity (Silver Spring); 2009 Mar; 17(3):504-9. PubMed ID: 19023279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of plasma adiponectin and cardiovascular risk profiles in nondiabetic uremic patients on peritoneal dialysis.
    Tsao YT; Hsu YJ; Chu NF; Lai CH; Chiu JS; Lin SH
    J Nephrol; 2008; 21(5):744-52. PubMed ID: 18949730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunologic abnormalities in children with acute Kawasaki disease.
    Ding XT; Yang XQ; Li CR; Shen J
    Chin Med J (Engl); 1993 Sep; 106(9):688-92. PubMed ID: 8287706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum interleukin-2 receptor in patients with Kawasaki disease].
    Matsubara T
    Arerugi; 1989 Jan; 38(1):49-56. PubMed ID: 2662945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nerve growth factor circulating levels are increased in Kawasaki disease: correlation with disease activity and reduced angiotensin converting enzyme levels.
    Falcini F; Cerinic MM; Ermini M; Generini S; Lombardi A; Pignone A; Leoncini G; Tirassa P; Aloe L
    J Rheumatol; 1996 Oct; 23(10):1798-802. PubMed ID: 8895162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.